Form 4: Molina Healthcare Director Sells Shares Under 10b5-1 Plan

Molina Healthcare director Ronna Romney reported the sale of 506 shares of common stock for approximately $146.92 per share, held indirectly by a trust, under a pre-arranged 10b5-1 plan.

Summary

• Director Ronna Romney sold 506 shares of Molina Healthcare, Inc. (MOH) common stock.
• The transaction occurred on March 12, 2026, at a volume-weighted average price of $146.92 per share.
• Actual selling prices for the shares ranged from $146.80 to $147.10.
• Following the sale, Ronna Romney beneficially owns 17,227 shares indirectly through the Ronna Romney Revocable Trust.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While a director sale can be perceived negatively, the small volume and execution under a 10b5-1 plan mitigate any strong negative sentiment, making it a routine disclosure.

Positives

• The transaction was executed under a Rule 10b5-1(c) plan, which indicates a pre-arranged sale not based on immediate inside information, promoting transparency.

Negatives

• A director selling shares, even a small amount, can sometimes be perceived as a minor negative signal by investors, though mitigated by the 10b5-1 plan.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that director sales are routine disclosures in the healthcare sector, often occurring under pre-arranged 10b5-1 plans. This specific transaction, involving a relatively small number of shares, is unlikely to significantly impact broader industry trends or competitive dynamics for Molina Healthcare, which operates in the managed care and health insurance industry.

Comparison to Industry Standards

• This transaction is a standard insider trading disclosure (Form 4) and does not provide company performance results that can be directly compared to industry benchmarks or specific competitor projects.
• Director sales of this magnitude are common across various industries and typically do not signal significant shifts in company fundamentals compared to larger institutional transactions or company-wide financial reports.

Corporate Governance

Related Party Transactions

• The 17,227 shares beneficially owned after the transaction are held indirectly by the Ronna Romney Revocable Trust, indicating a related party holding.

Stakeholder Impact

• Shareholders: Minor potential for negative sentiment due to a director sale, though this is largely mitigated by the small volume and the transaction being executed under a pre-arranged 10b5-1 plan.

Key Dates

Recommendation

The sale of 506 shares by a director, while a disclosure, is a very small transaction for a company of Molina Healthcare's size and was executed under a pre-arranged 10b5-1 plan. This event does not provide a strong signal for either buying or selling the stock, thus a 'hold' recommendation is appropriate as it does not alter the fundamental investment thesis.

Keywords

Molina Healthcare, MOH, Ronna Romney, Director Sale, Insider Transaction, Form 4, Stock Sale, 10b5-1 Plan, Healthcare Stock